Want to join the conversation?
Jon Groberg of UBS asks about the outlook for 2017. $A said it has a rich pipeline of new product introductions coming in 4Q16 and in FY17. $A expects pharma and China markets to be significant growth drivers but believes they will be below double digit levels. $A is forecasting low single digit growth for FY17.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.